Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients

被引:0
|
作者
Mateusz Kurzawski
Marek Droździk
Janina Suchy
Grzegorz Kurzawski
Monika Białecka
Wanda Górnik
Jan Lubiński
机构
[1] Pomeranian Medical University,Department of Pharmacology
[2] Pomeranian Medical University,Hereditary Cancer Center, Department of Genetics and Patomorphology
关键词
Familial Adenomatous Polyposis; 3435TT Genotype; C3435T Polymorphism; Colon Cancer Patient; MDR1 Gene;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:389 / 394
页数:5
相关论文
共 50 条
  • [1] Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients
    Kurzawski, M
    Drozdzik, M
    Suchy, J
    Kurzawski, G
    Bialecka, M
    Górnik, W
    Lubinski, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (5-6) : 389 - 394
  • [2] P-glycoprotein drug transporter MDR1 gene polymorphism in renal transplant patients with and without gingival overgrowth
    Drozdzik, M
    Mysliwiec, K
    Lewinska-Chelstowska, M
    Banach, J
    Drozdzik, A
    Grabarek, J
    [J]. JOURNAL OF CLINICAL PERIODONTOLOGY, 2004, 31 (09) : 758 - 763
  • [3] Polymorphism in the P-glycoprotein drug transporter MDR1 gene in renal transplant patients treated with cyclosporin A in a Polish population
    Kotrych, Katarzyna
    Sulikowski, Tadeusz
    Domanski, Leszek
    Bialecka, Monika
    Drozdzik, Marek
    [J]. PHARMACOLOGICAL REPORTS, 2007, 59 (02) : 199 - 205
  • [4] Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
    Cascorbi, I
    Gerloff, T
    Johne, A
    Meisel, C
    Hoffmeyer, S
    Schwab, M
    Schaeffeler, E
    Eichelbaum, M
    Brinkmann, U
    Roots, I
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 169 - 174
  • [5] Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease
    Drozdzik, M
    Bialecka, M
    Mysliwiec, K
    Honczarenko, K
    Stankiewicz, J
    Sych, Z
    [J]. PHARMACOGENETICS, 2003, 13 (05): : 259 - 263
  • [6] ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO THE MDR1 GENE (P-GLYCOPROTEIN)
    CLUGSTON, C
    BROWN, R
    [J]. BRITISH JOURNAL OF CANCER, 1989, 60 (03) : 496 - 496
  • [7] Relationship of MDR1 gene polymorphism and P-glycoprotein expression in Chinese refractory lupus nephritis
    Jun Zhou
    Hua Lin
    Ju Chen
    [J]. Biologia, 2021, 76 : 367 - 374
  • [8] Determining MDR1/P-glycoprotein expression in breast cancer
    Faneyte, IF
    Kristel, PMP
    van de Vijver, MJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (01) : 114 - 122
  • [9] Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein
    Kurata, Y
    Ieiri, I
    Kimura, M
    Morita, T
    Irie, S
    Urae, A
    Ohdo, S
    Ohtani, H
    Sawada, Y
    Higuchi, S
    Otsubo, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) : 209 - 219
  • [10] MDR1/P-GLYCOPROTEIN EXPRESSION IN COLORECTAL-CANCER
    LINN, SC
    GIACCONE, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (7-8) : 1291 - 1294